Switch to:
More From Other Websites
Nasdaq stocks posting largest percentage increases Oct 02 2014
Can Repros Therapeutics Shares Still More Than Double? Sep 29 2014
Repros Therapeutics (RPRX) Worth Watching: Stock Up 17% Sep 29 2014
US STOCKS-Biotech among biggest Nasdaq gainers Sep 26 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Sep 26 2014
FDA Schedules Type B Pre-NDA Meeting With Repros Sep 26 2014
Androxal(R) Second Pivotal Study Achieves Superiority in Top Line Analysis for Both Co-Primary... Sep 25 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Sep 22 2014
[$$] FDA Recommendation Doesn't Apply to Androxal, Repros Says Sep 22 2014
Repros Gives Update on Androxal(R) With Respect to Recent FDA Advisory Panel Outcome and Announces... Sep 22 2014
Rite Aid Plunges As Full-Year Outlook Dims Sep 18 2014
Why Repros Therapeutics (RPRX) Stock Plummeted to a One-Year Low Today Sep 18 2014
Repros Therapeutics (RPRX) Crumbles: Stock Falls by 10.5% Sep 18 2014
Infoblox Inc. (BLOX) Climbs On Earnings Sep 05 2014
Repros Reports Encouraging Late-Stage Data on Androxal Aug 28 2014
Williams-Sonoma Stumbles After Yesterday's Surge Aug 28 2014
Why Repros Therapeutics (RPRX) Stock Is Surging Today Aug 28 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Aug 28 2014
Androxal(R) Achieves Superiority in Top Line Analysis for Both Co-Primary Endpoints and Various... Aug 27 2014
Repros Therapeutics (RPRX) Shows Strength: Stock Rises 5% Aug 22 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK